Ranitidine versus cimetidine in the management of acute upper gastrointestinal tract bleeding. 1984

A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis

Ranitidine and cimetidine were compared with respect to their effect on preventing the continuation or recurrence of acute upper gastrointestinal bleeding secondary to peptic ulcer disease. Fifty patients were randomly allocated to treatment with either ranitidine or with cimetidine. The two groups were comparable for age, sex, and severity of hemorrhage. There was no statistically significant difference in outcome between the groups when assessing need for surgery, total number of units in blood required, days in hospital, incidence of rebleeding, or deaths. However, there was a trend in favor of ranitidine: only one ranitidine-treated patient went to operation versus four of the cimetidine group. In addition, the number of rebleeds was higher in the cimetidine group (14) compared to the ranitidine group (1). Two patients in each group died. Therefore, ranitidine appears to be comparable to cimetidine in the management of patients with acute upper gastrointestinal tract bleeding. However, this study did not include a placebo group, and thus the generalized use of H2-receptor blockers in all patients with acute upper gastrointestinal tract bleeding has not been proven.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010438 Peptic Ulcer Hemorrhage Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT. Hemorrhage, Peptic Ulcer,Peptic Ulcer Hemorrhages,Ulcer Hemorrhage, Peptic
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
April 1979, British medical journal,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
June 1983, The New England journal of medicine,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
February 1987, Alimentary pharmacology & therapeutics,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
November 1983, The New England journal of medicine,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
March 1979, British medical journal,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
January 2000, Current medical research and opinion,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
September 1972, Harefuah,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
January 2022, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society,
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
July 1986, Archives of surgery (Chicago, Ill. : 1960),
A B Thomson, and T Maguire, and R H Wensel, and R W Sherbaniuk, and R J Bailey, and P Kirdeikis
March 1953, The New England journal of medicine,
Copied contents to your clipboard!